Roberto Piva

Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma

Ramona Crescenzo, Francesco Abate, Elena Lasorsa et al. · Cancer Cell · 2015 · 429 citations · Full text

Lymphoid Neoplasia, Medicine, Convergent Mutations +8

Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

Alberto Zamò, Roberto Chiarle, Roberto Piva et al. · Oncogene · 2002 · 388 citations

Hematological Malignancy, Lymphoid Neoplasia, Hematopoietic Cells +9

Exercise training intervention after coronary angioplasty: the ETICA trial

Romualdo Belardinelli, Ivana Paolini, Giovanni Cianci et al. · Journal of the American College of Cardiology · 2001 · 347 citations

Percutaneous Coronary Intervention, Exercise, Exercise Physiology +9

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

Roberto Piva, Bruce Ruggeri, Michael Williams et al. · Blood · 2007 · 252 citations · Full text

NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors

Roberto Chiarle, Jerald Z. Gong, Ilaria Guasparri et al. · Blood · 2003 · 247 citations · Full text